Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.52 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.52 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | ALPI | P09923 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27638669 | 0.91 | SLC1A3 (0.45) | SLC1A3SLC1A2SLC1A1ALDH1A1HPGD | |
| SCHEMBL14615873 | 0.81 | ALDH1A1 (0.63) | SLC1A3SLC1A2SLC1A1ALDH1A1HDAC3 | |
| SCHEMBL3448866 | 0.81 | ALDH1A1 (0.63) | SLC1A3SLC1A2SLC1A1ALDH1A1HDAC3 | |
| SCHEMBL6734115 | 0.80 | SLC1A3 (0.59) | SLC1A3SLC1A2SLC1A1HPGDALPI | |
| SCHEMBL6734110 | 0.80 | SLC1A3 (0.59) | SLC1A3SLC1A2SLC1A1HPGDALPI | |
| Hydrochloric Acid SCHEMBL7461056 | 0.79 | SLC1A3 (0.57) | SLC1A3SLC1A2SLC1A1HPGDALPI | |
| Hydrochloric Acid SCHEMBL7461064 | 0.79 | SLC1A3 (0.57) | SLC1A3SLC1A2SLC1A1HPGDALPI | |
| SCHEMBL7291294 | 0.78 | DPP7 (0.54) | SLC1A3SLC1A2SLC1A1ALDH1A1HPGD | |
| SCHEMBL7291298 | 0.78 | DPP7 (0.54) | SLC1A3SLC1A2SLC1A1ALDH1A1HPGD | |
| SCHEMBL1976382 | 0.78 | DPP8 (0.66) | SLC1A1ALDH1A1HDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4243869-A1 | BI-SPECIFIC ANTIBODIES COMPRISING ANTI-CD137 BINDING MOLECULES | Lyvgen Biopharma Holdings Limited (KY) | 2023-09-20 | — | — | EP | disclosed |
| EP-4048701-A1 | ANTI-CD40 BINDING MOLECULES AND BI-SPECIFIC ANTIBODIES COMPRISING SUCH | Lyvgen Biopharma Holdings Limited (KY) | 2022-08-31 | — | — | EP | disclosed |
| WO-2022103780-A1 | BI-SPECIFIC ANTIBODIES COMPRISING ANTI-CD137 BINDING MOLECULES | LYVGEN BIOPHARMA HOLDINGS LIMITED (KY) | 2022-05-19 | — | — | WO | disclosed |
| WO-2021081303-A1 | ANTI-CD40 BINDING MOLECULES AND BI-SPECIFIC ANTIBODIES COMPRISING SUCH | Lyvgen Biopharma (Suzhou) Co., Ltd. (CN) | 2021-04-29 | — | — | WO | disclosed |
| EP-3240570-A1 | BISPECIFIC ANTIBODIES AGAINST PLASMA KALLIKREIN AND FACTOR XII | Dyax Corp. (US) | 2017-11-08 | — | — | EP | disclosed |
| WO-2016109774-A1 | BISPECIFIC ANTIBODIES AGAINST PLASMA KALLIKREIN AND FACTOR XII | DYAX CORP. (US) | 2016-07-07 | — | — | WO | disclosed |
| EP-2640745-A2 | ANTIBODY DERIVATIVES | Allozyne, Inc. (US) | 2013-09-25 | — | — | EP | disclosed |
| WO-2012032181-A9 | ANTIBODY DERIVATIVES | ALLOZYNE, INC (US) | 2013-06-13 | — | — | WO | disclosed |
| WO-2012032181-A2 | NOVEL ANTIBODY DERIVATIVES | ALLOZYNE, INC (US) | 2012-03-15 | — | — | WO | disclosed |